Article Information
History
- February 5, 2024.
Article Versions
- Version 1 (September 14, 2023 - 20:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Iris Ganser, MSca,b,
- Prof David L Buckeridge, PhDb,
- Prof Jane Heffernan, PhDc,
- Mélanie Prague, PhDa,d,e and
- Prof Rodolphe Thiébaut, PhDa,d,e,f,*
- aUniv. Bordeaux, Inserm, BPH Research Center, SISTM Team, UMR 1219, Bordeaux, France
- bMcGill Health Informatics, School of Population and Global Health, McGill University, Montreal, Quebec, Canada
- cMathematics & Statistics, Centre for Disease Modelling, York University, Toronto, Ontario, Canada
- dInria, Inria Bordeaux - Sud-Ouest, Talence, France
- eVaccine Research Institute, F-94010 Creteil, France
- fBordeaux University Hospital, Medical Information Department, Bordeaux, France
- ↵*Corresponding author: Rodolphe Thiebaut, rodolphe.thiebaut{at}u-bordeaux.fr
Posted February 05, 2024.
Estimating the population effectiveness of interventions against COVID-19 in France: a modelling study
